SABATINI BRENT (SVP, Chief Accounting Officer) sold 2.0% of their position (1.43K shares) of VIR BIOTECHNOLOGY, INC. on the open market
Open‑market sale worth $13.6K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/26/2026ACC: 0001628280-26-012396
Officer· SVP, Chief Accounting Officer
Since Feb 2026
-1.43K
Net shares
Net seller
$13.6K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.43K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.43K
Price / share
$9.53
Trade value
$13.63K
% of position
2.0%
2/24/2026
71.04K→69.61K
Total
Net shares
−1.43K
Net value
-$13.63K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/24/2026 | S · Sale | −1.43K | $9.53 | $13.63K | 2.0% | 71.04K | 69.61K |
| Total | −1.43K | -$13.63K | ||||||
Derivative Transactions0
No derivative transactions reported